TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11511429

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no carvedilol)
Number of subjects: 14
Study: 9745440

Group type: EXPERIMENTAL
Intervention: Estrogen
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7872724

Group type: EXPERIMENTAL
Intervention: Healthy Chinese hepatitis B carriers
Number of subjects: 78

Group type: COMPARATOR
Intervention: Normal Chinese individuals
Number of subjects: 78
Study: 3323165

Group type: EXPERIMENTAL
Intervention: Roxithromycin 300 mg daily
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Roxithromycin 150 mg bd
Number of subjects: 227
Study: 31664782

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30137297

Group type: EXPERIMENTAL
Intervention: Behavioural intervention in pregnancy with online support; Duration: Not specified; Dosage: Not specified
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Online support; Duration: Not specified; Dosage: Not specified
Number of subjects: 22
Study: 29187310

Group type: EXPERIMENTAL
Intervention: Grade III passive lumbar rotational mobilization
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 24
Study: 26522334

Group type: COMPARATOR
Intervention: 74 Gy in 37 fractions
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: 60 Gy in 20 fractions
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: 57 Gy in 19 fractions
Number of subjects: 2100
Study: 24095588

Group type: EXPERIMENTAL
Intervention: Omega-3 LCPUFA supplementation (277.8mg DHA and 39.0mg EPA/capsule)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omega-3 LCPUFA supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (high oleic acid sunflower seed oil)
Number of subjects: 0
Study: 21782381

Group type: EXPERIMENTAL
Intervention: Hydroxypropyl methylcellulose (HPMC) 2% gel (Cornea_Protect)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Balanced salt solution (BSS)
Number of subjects: 97
Study: 19361739

Group type: EXPERIMENTAL
Intervention: Acetaminophen 600 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 17065697

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: Combined training
Number of subjects: 1003

Group type: COMPARATOR
Intervention: Dietary, drug, and insulin treatments
Number of subjects: 1003
Study: 15079008

Group type: EXPERIMENTAL
Intervention: Cannabis extract (oral cannador)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cannabis extract
Number of subjects: 14
Study: 14512073

Group type: EXPERIMENTAL
Intervention: Enrollment in an intervention trial
Number of subjects: 2280
Study: 10721462

Group type: EXPERIMENTAL
Intervention: Desensitization (group 1)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Rechallenge (group 2)
Number of subjects: 73
Study: 8933491

Group type: EXPERIMENTAL
Intervention: Countermovement Jump (CMJ)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Squat Jump (SJ)
Number of subjects: 6
Study: 1599856

Group type: EXPERIMENTAL
Intervention: Role of clinical coordinator in managing patient follow-up
Number of subjects: 0
Study: 3890223

Group type: EXPERIMENTAL
Intervention: Rosaramicin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Ampicillin plus probenecid
Number of subjects: 39
Study: 30471974

Group type: EXPERIMENTAL
Intervention: Educational patient hand hygiene intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 29506017

Group type: EXPERIMENTAL
Intervention: Referral Support Actions (RSA) for RA
Number of subjects: 571

Group type: COMPARATOR
Intervention: Control group (no intervention) for RA
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Referral Support Actions (RSA) for axial SpA
Number of subjects: 571

Group type: COMPARATOR
Intervention: Control group (no intervention) for axial SpA
Number of subjects: 571
Study: 27096673

Group type: EXPERIMENTAL
Intervention: Lung hyperinflation by mechanical ventilator (MVH Group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isolated tracheal aspiration (Control Group)
Number of subjects: 50
Study: 24794837

Group type: EXPERIMENTAL
Intervention: Reading (magazine or electronic device)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Listening to self‐selected relaxing music
Number of subjects: 65

Group type: COMPARATOR
Intervention: Resting
Number of subjects: 65
Study: 22092547

Group type: EXPERIMENTAL
Intervention: PEEK clips
Number of subjects: 30

Group type: COMPARATOR
Intervention: POM clips
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both PEEK and POM clips
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Retention force over time
Number of subjects: 30
Study: 19883386

Group type: EXPERIMENTAL
Intervention: Exercise program aimed at preventing groin injuries (n=27 clubs)
Number of subjects: 1211

Group type: COMPARATOR
Intervention: Control group training as usual (n=28 clubs)
Number of subjects: 1211
Study: 19030136

Group type: EXPERIMENTAL
Intervention: Carbohydrate and electrolytes (CHO)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Flavored-water placebo with electrolytes (PLA)
Number of subjects: 9
Study: 16477089

Group type: EXPERIMENTAL
Intervention: d‐amphetamine
Number of subjects: 31

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 31
Study: 12032647

Group type: EXPERIMENTAL
Intervention: Diet S (stearic acid enriched)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Diet P (palmitic acid enriched)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Diet S
Number of subjects: 9

Group type: COMPARATOR
Intervention: Diet P
Number of subjects: 9
Study: 10075068

Group type: EXPERIMENTAL
Intervention: Sufentanil (1 microg/kg bolus followed by 0.005 microg/kg/min infusion)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fentanyl (10 microg/kg bolus followed by 0.075 microg/kg/min infusion)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Alfentanil (100 microg/kg bolus followed by 0.7 microg/kg/min infusion)
Number of subjects: 6
Study: 10150534

Group type: EXPERIMENTAL
Intervention: LEP (Mail-delivered, self-instructional exercise packets)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FFP (Another form of exercise packet)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SEP (Standard exercise packet)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (combined)
Number of subjects: 0
Study: 1828366

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil with continuous epidural infusion of 0.125% bupivacaine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intravenous sufentanil with continuous intravenous infusion of 0.125% bupivacaine
Number of subjects: 28
Study: 6785099

Group type: EXPERIMENTAL
Intervention: Intravenously infused saralasin (dose 0.01‐10 microgram kg‐1 min‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infusion of saralasin at the highest dose directly into the renal artery of denervated kidneys
Number of subjects: 0
Study: 31586293

Group type: EXPERIMENTAL
Intervention: Methimazole (MMI) 10 mg for 6 weeks prior to 131I therapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 31369674

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 46
Study: 28647384

Group type: EXPERIMENTAL
Intervention: Avoid unhealthy food/approach healthy food training
Number of subjects: 200

Group type: COMPARATOR
Intervention: Other conditions (not specified)
Number of subjects: 200
Study: 25841622

Group type: EXPERIMENTAL
Intervention: Acupuncture-like transcutaneous electrical nerve stimulation (ALTENS)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Pilocarpine (PC)
Number of subjects: 148
Study: 23783643

Group type: EXPERIMENTAL
Intervention: Combination of ofloxacin (200 mg) and roxithromycin (150 mg) twice daily for 3 months
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combination of ofloxacin and roxithromycin
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 20957498

Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg once daily
Number of subjects: 329

Group type: COMPARATOR
Intervention: mosapride 5 mg thrice daily
Number of subjects: 329
Study: 19564557

Group type: EXPERIMENTAL
Intervention: Elevated depression symptoms (Beck Depression Inventory‐II >or=14)
Number of subjects: 974

Group type: EXPERIMENTAL
Intervention: Unmarried status in depressed patients
Number of subjects: 974
Study: 16928807

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 2231

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2231

Group type: EXPERIMENTAL
Intervention: Both groups (Captopril and Placebo)
Number of subjects: 2231
Study: 14722778

Group type: EXPERIMENTAL
Intervention: Biering‐Sorensen muscle endurance (BSME) test using near infrared spectroscopy (NIRS)
Number of subjects: 17
Study: 11473681

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide 0.5 mg twice daily for 1 month followed by 0.25 mg daily for the next 2 months
Number of subjects: 49

Group type: COMPARATOR
Intervention: Nebulized budesonide 0.1 mg twice daily throughout the 3-month treatment period
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both treatment groups (high-dose and low-dose)
Number of subjects: 49
Study: 9440663

Group type: EXPERIMENTAL
Intervention: Prophylaxis for PCP and toxoplasmosis with trimethoprim‐sulfamethoxazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylaxis for MAC with azithromycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylaxis for MAC with rifabutin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir for the prevention of CMV infection
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0
Study: 8299805

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intracervical insemination
Number of subjects: 8
Study: 3263868

Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 400 micrograms
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 100 micrograms
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 200 micrograms
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) 200 micrograms (multiple 5 day administration)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: MDP-Lys(L18) (high-dose group)
Number of subjects: 35
Study: 5297559

Group type: EXPERIMENTAL
Intervention: BCG vaccine (for negative reactors)
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Smallpox vaccine
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Smallpox vaccine with BCG for negative reactors
Number of subjects: 1099

Group type: COMPARATOR
Intervention: Control group (no vaccination)
Number of subjects: 1099
Study: 83108

Group type: EXPERIMENTAL
Intervention: Slide-tape program with pharmacist present (Group 1)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Slide-tape program without pharmacist present (Group 2)
Number of subjects: 34
Study: 31898768

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Body acupuncture (BA)
Number of subjects: 36
Study: 31296568

Group type: EXPERIMENTAL
Intervention: CHAT (brief motivational intervention)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 294
Study: 30093799

Group type: EXPERIMENTAL
Intervention: Resonance Voice Therapy (RVT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cervical-thoracic therapy
Number of subjects: 20
Study: 27121901

Group type: EXPERIMENTAL
Intervention: PP-501-B
Number of subjects: 81

Group type: COMPARATOR
Intervention: Restylane Perlane
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: PP-501-B and Restylane Perlane
Number of subjects: 81
Study: 25013367

Group type: EXPERIMENTAL
Intervention: Chuanhu anti-gout mixture
Number of subjects: 176

Group type: COMPARATOR
Intervention: Colchicine
Number of subjects: 176
Study: 23060319

Group type: COMPARATOR
Intervention: SPC(2+6) design
Number of subjects: 51

Group type: COMPARATOR
Intervention: SPC(4+4) design
Number of subjects: 51

Group type: COMPARATOR
Intervention: SPC designs (SPC(2+6), SPC(4+4), SPC(6+6))
Number of subjects: 51
Study: 19914051

Group type: EXPERIMENTAL
Intervention: Dexamethasone 5 mg IV (Group D; n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (Group S; n = 30)
Number of subjects: 60
Study: 17804333

Group type: EXPERIMENTAL
Intervention: Ketac‐Cem (3M ESPE, St Paul, MN)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond/Clearfil AP‐X (Kuraray, New York, NY)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Maxcem (Kerr, Orange, CA)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Negative control group (n = 5)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Positive control group (n = 5)
Number of subjects: 55
Study: 12690049

Group type: EXPERIMENTAL
Intervention: Morphine-6-beta-glucuronide (M6G) infusion (low dose, 2 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine infusion (positive control)
Number of subjects: 0
Study: 10743458

Group type: EXPERIMENTAL
Intervention: Propofol anaesthesia with clinical signs monitoring
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propofol anaesthesia with EEG threshold method
Number of subjects: 30
Study: 8770484

Group type: EXPERIMENTAL
Intervention: Anesthesia infusion sleeve (AIS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard sheath
Number of subjects: 20
Study: 1345035

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (2 g per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3160209

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 203

Group type: COMPARATOR
Intervention: Fentanyl/Droperidol
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study: 31138316

Group type: EXPERIMENTAL
Intervention: Continued SDZ ETN (50 mg subcutaneous once-weekly)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Switched to SDZ ETN (50 mg subcutaneous once-weekly)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Continued SDZ ETN
Number of subjects: 279

Group type: COMPARATOR
Intervention: Switched to SDZ ETN
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 279
Study: 27176631

Group type: EXPERIMENTAL
Intervention: Lidocaine with clonidine (15 μg mL-1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lidocaine with epinephrine (12.5 μg mL-1)
Number of subjects: 100
Study: 25461825

Group type: EXPERIMENTAL
Intervention: 2 mA a‐tDCS
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1 mA a‐tDCS
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 9
Study: 23949563

Group type: EXPERIMENTAL
Intervention: Low-volume morning-only polyethylene glycol with specially designed test meals (LV-PEG with TM)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Standard-volume split-dose polyethylene glycol with standard diet (SV-PEG with SD)
Number of subjects: 197
Study: 23272429

Group type: EXPERIMENTAL
Intervention: Manual Vacuum Aspiration (MVA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dilatation and Curettage (DNC)
Number of subjects: 100
Study: 19413144

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - sleep education, stimulus control, and time‐in‐bed restrictions; 20 patients with primary insomnia and 21 with comorbid insomnia
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sleep Hygiene (SH) - education about aspects of lifestyle and the bedroom environment that affect sleep; 20 patients with primary insomnia and 20 with comorbid insomnia
Number of subjects: 81
Study: 18000777

Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition
Number of subjects: 646

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 646
Study: 15151490

Group type: EXPERIMENTAL
Intervention: Active cycle of breathing techniques (ACBT) with non-invasive ventilation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (non-invasive ventilation alone)
Number of subjects: 34
Study: 11713064

Group type: EXPERIMENTAL
Intervention: Topical fluorometholone (FML) six times daily for 4 weeks (group 1)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Topical fluorometholone (FML) three times daily for 4 weeks (group 2)
Number of subjects: 31
Study: 9334554

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg of methylphenidate twice per day
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg of methylphenidate twice per day
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 8390511

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-fat diet
Number of subjects: 24
Study: 3720365

Group type: EXPERIMENTAL
Intervention: Epidural morphine at regular intervals
Number of subjects: 20

Group type: COMPARATOR
Intervention: Subcutaneous nicomorphine on demand
Number of subjects: 20
Study: 30025941

Group type: EXPERIMENTAL
Intervention: Computerized Scheduling Program (CSP)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard e-mail/phone scheduling
Number of subjects: 124
Study: 28158197

Group type: EXPERIMENTAL
Intervention: MIRT with treadmill‐plus
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MIRT with Lokomat®
Number of subjects: 24
Study: 25970759

Group type: EXPERIMENTAL
Intervention: Topical haemoglobin spray
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 72
Study: 22999321

Group type: EXPERIMENTAL
Intervention: Higher pulmonary artery systolic pressures (PASP)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Post-operative AF patients
Number of subjects: 174
Study: 21504072

Group type: EXPERIMENTAL
Intervention: Cefixim 400 mg/day for 5 days
Number of subjects: 104

Group type: COMPARATOR
Intervention: Ciprofloxacin 250‐500 mg twice a day for 5 days
Number of subjects: 104
Study: 19352378

Group type: EXPERIMENTAL
Intervention: Walnut group (30 g per day walnuts)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Walnut group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (low-fat dietary advice)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study: 16917901

Group type: EXPERIMENTAL
Intervention: Noninvasive assessment method for energy expenditure (EE) based on regression modeling using heart rate (HR) and other variables
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Noninvasive assessment method for energy expenditure (EE)
Number of subjects: 74
Study: 15253118

Group type: EXPERIMENTAL
Intervention: Bod Pod
Number of subjects: 160

Group type: COMPARATOR
Intervention: DXA
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Comparison of Bod Pod and DXA
Number of subjects: 160
Study: 11751712

Group type: EXPERIMENTAL
Intervention: Salt-sensitive subjects
Number of subjects: 28

Group type: COMPARATOR
Intervention: Salt-resistant subjects
Number of subjects: 28
Study: 9591737

Group type: EXPERIMENTAL
Intervention: Glucagon infusion at 0.4 ng x kg(‐1) x min(‐1)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Glucagon infusion at 1.2 ng x kg(‐1) x min(‐1)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Higher rate of glucagon infusion (1.2 ng x kg(‐1) x min(‐1))
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Glucagon excess
Number of subjects: 5
Study: 7872910

Group type: EXPERIMENTAL
Intervention: Weight Training (WT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Non-Weight-Trained Control (NWT)
Number of subjects: 14
Study: 3061416

Group type: EXPERIMENTAL
Intervention: Zidovudine (AZT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29960156

Group type: EXPERIMENTAL
Intervention: Olive oil/LCT (OO/LCT)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Long-chain triglycerides (LCT)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Medium/long-chain triglycerides
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Mix of LCT/MCT/OO/fish oil
Number of subjects: 67
Study: 26965560

Group type: EXPERIMENTAL
Intervention: Combination therapy (solifenacin 5 mg + mirabegron 50 mg)
Number of subjects: 2174

Group type: COMPARATOR
Intervention: Solifenacin 5 mg
Number of subjects: 2174

Group type: COMPARATOR
Intervention: Solifenacin 10 mg
Number of subjects: 2174
Study: 25640020

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 23084955

Group type: EXPERIMENTAL
Intervention: Exercise therapy (ET)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Exercise therapy with adjunctive manual therapy (ET+MT)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 131
Study: 21199294

Group type: EXPERIMENTAL
Intervention: Single-dose tenofovir/emtricitabine (TDF/FTC)
Number of subjects: 397

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 397
Study: 18040663

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional insulin therapy (CIT)
Number of subjects: 92
Study: 16825690

Group type: EXPERIMENTAL
Intervention: 416 microg [6S]-5-MTHF/d
Number of subjects: 144

Group type: COMPARATOR
Intervention: 400 microg folic acid/d
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 208 microg [6S]-5-MTHF/d
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 14506195

Group type: EXPERIMENTAL
Intervention: 186Re-labeled BIWA 4 (bivatuzumab) at doses of 20, 30, 40, 50, and 60 mCi/m2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 186Re-labeled BIWA 4 (bivatuzumab) at 60 mCi/m2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 186Re-labeled BIWA 4 (bivatuzumab)
Number of subjects: 20
Study: 10699324

Group type: COMPARATOR
Intervention: cpts 248/404 RSV vaccine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: sequential immunization
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: simultaneous immunization
Number of subjects: 120